Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Vaccine
Breast cancer prognostic information is aided by monocyte chemotactic protein-1
March 23rd, 2006
Monocyte chemotactic protein-1 levels provide prognostic information in breast cancer patients. "We studied serum monocyte chemotactic protein-1 (MCP-1) levels in breast cancer patients in relationship to their clinicopathologic variables and immune response to a HER-2/neu E75 vaccine," researchers in the United States report. Zia A. Dehqanzada and colleagues at the Uniformed Services University of the Health Sciences explained, "We measured MCP-1 levels in 32 HER-2/neu+ breast cancer patients before and after vaccination with a HER-2/neu E75 peptide + granulocyte macrophage colony-stimulating factor vaccine. Clinical...
Source: Women's Health Weekly (2006-03-23)
|
